本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ARS PHARMACEUTICALS INC

14.88
+0.0000
盘后14.900.0201+0.14%19:58 EDT
成交量:155.04万
成交额:2,300.49万
市值:14.60亿
市盈率:186.00
高:15.09
开:14.79
低:14.43
收:14.88
数据加载中...
2025/04/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/20

重要事件披露

Form 8-K - Current report
2025/03/05

重要事件披露

Form 8-K - Current report
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/06

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities